default image

Urologie

Information and services of the department

  • Number of inpatient cases: 133

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 43
Hyperplasia of prostate (N40) 13
Hydrocele and spermatocele - Hydrocele unspecified (N43.3) 10
Calculus of kidney and ureter - Calculus of ureter (N20.1) 9
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 7
Unspecified haematuria (R31) 6
Obstructive and reflux uropathy (N13.3) 5
Redundant prepuce phimosis and paraphimosis (N47) 5
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) 4
Malignant neoplasm of penis - Malignant neoplasm of glans penis (C60.1) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 77
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 56
Insertion, exchange or removal of a ureteral stent (8-137.00) 20
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22) 12
Removal of stones, foreign bodies or collections of blood from the bladder by endoscopy (5-570.4) 11
(9-984.7) 11
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 10
Surgical occlusion of a hydrocele on the testicle (5-611) 10
Examination of the urethra and the urinary bladder by endoscopy (1-661) 8
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 8

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
27 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
22 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year) Famulaturen
No. Training in other healing professions Comment
HB19 Nursing professionals Voraussetzungen: Vollendung des 16. Lebensjahres, Realschulabschluss, Ausbildungsdauer, 3 Jahre Hinweis: Beginn der Ausbildung erfolgt jeweils zum 01. September
HB07 Surgical technical assistant (m/f) Voraussetzungen: Vollendung des 16. Lebensjahres, Realschulabschluss, Ausbildungsdauer, 3 Jahre Hinweis: Beginn der Ausbildung erfolgt jeweils zum 01. September
HB05 Medical technical radiology assistant (MTRA) (m/f)

Adina Metzig

Qualitätsbeauftragte

Phone: 03433 -21-1521
Mail: ed.anas@giztem.anida

PD Dr. med. Kay-Rüdiger Kohlhaw

ärztlicher Direktor

Phone: 03437 -9378-4502
Mail: ed.anas@wahlhok.yak

Dr. med. Andreas Klamann

Phone: 03433 -21-1701
Mail: ed.anas@nnamalk.saerdna

PD Dr. med. Kay-Rüdiger Kohlhaw

ärztlicher Direktor

Phone: 03437 -9378-4502
Mail: ed.anas@wahlhok.yak